UK MHRA · July 27, 2026

Safety review: bladder anticholinergics and risk of dementia

Original title: Research: Bladder Anticholinergics: review of risk of dementia

Public assessment of safety data on dementia risk associated with bladder anticholinergic medicines.

High obligation Sector Pharmaceuticals Public Health UK Pharmacovigilance

Public Assessment Report on the safety review of the available data on the risk of dementia with the use of bladder anticholinergic medicines.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.